desogestrel has been researched along with Body Weight in 52 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 14 (26.92) | 18.7374 |
| 1990's | 16 (30.77) | 18.2507 |
| 2000's | 16 (30.77) | 29.6817 |
| 2010's | 6 (11.54) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Amiri, Z; Azimi Nekoo, E; Haghollahi, F; Noroozi, M; Norouzi Javidan, A; Ramezanzadeh, F; Sadat Hosseini, F; Yekaninejad, MS | 1 |
| Diedrich, JT; Drey, EA; Harper, CC; Sokoloff, A; Steinauer, JE; Upadhyay, UD | 1 |
| El Beitune, P; Foresti Jiménez, M; Malerba, H; Pontremoli Salcedo, M; Villas-Boas, J; Vilodre, LC | 1 |
| Madden, T; Omvig, K; Peipert, JF; Silva Dos Santos, PN | 1 |
| Bian, ML; Cao, XM; Cheng, LN; Fan, GS; Han, ZY; Huang, ZR; Jing, XP; Li, J; Wu, SY; Xiong, CL; Xiong, ZA; Yue, TF | 1 |
| Reader, CA | 1 |
| Brito, MB; Ferriani, RA; Quintana, SM; Silva de Sá, MF; Vieira, CS; Yazlle, ME | 1 |
| Cheng-Liang, X; Guang-Sheng, F; Jian, L; Li-Nan, C; Mei-Lu, B; Shu-Ying, W; Tian-Fu, Y; Xiao-Ming, C; Xiao-Ping, J; Zheng-Ai, X; Zi-Rong, H; Zi-Yan, H | 1 |
| Barbieri, M; de Araujo, FF; de Queiroz, FT; Guazzelli, CA; Torloni, MR | 1 |
| Buicu, C; Endrikat, J; Gaspard, U; Gerlinger, C; Heithecker, R; Lefebvre, P; Scheen, A | 1 |
| Cagnacci, A; Melis, GB; Orrù, M; Paoletti, AM; Pilloni, M; Renzi, A; Volpe, A | 1 |
| Agrawal, A; Robinson, C | 1 |
| Cui, GH; Guo, Y; Xue, SP; Yang, ZJ; Ye, WS | 1 |
| Anderson, RA; Apter, D; Brady, BM; Devroey, P; Hay, CJ; Huhtaniemi, I; Kersemaekers, WM; Nieschlag, E; Osmanagaoglu, K; Pollanen, P; Wu, FC; Zitzmann, M | 1 |
| Aubeny, E; Bastianelli, C; Birkhäuser, MH; Bjertnaes, A; Gruber, CJ; Knudsen, T; Lete, I; Lindh, I; Milsom, I; Rokstad, K | 1 |
| Batashki, I; Gŭrova, A; Markova, D; Milchev, N; Uchikova, E | 1 |
| Hund, M; Merki-Feld, GS | 1 |
| Burkman, RT; Fisher, AC; LaGuardia, KD | 1 |
| Weijers, MJ | 2 |
| Samsioe, G | 1 |
| Geissler, KH | 1 |
| Dik, M; Eckert, H; Hönes, S; Schindler, AE | 1 |
| Bruyniks, N; Kovacs, L; Rákóczi, I | 1 |
| Akerlund, M; Røde, A; Westergaard, J | 1 |
| Cachrimanidou, AC; Hellberg, D; Nilsson, S; Olsson, SE; Sikström, B; Waldenström, U | 1 |
| Ekwempu, CC; Giwa-Osagie, OF; Ladipo, OA; Ulasi, JN; van Dierendonck, B | 1 |
| Coelingh-Bennink, HJ; Davies, GC; Feng, LX; Newton, JR; Van Beek, A | 1 |
| Rubio Lotvin, B | 1 |
| Borm, GF; Coenen, CM; Rolland, R; Thomas, CM | 1 |
| Düsterberg, B; Endrikat, J; Jaques, MA; Mayerhofer, M; Müller, U; Pelissier, C | 1 |
| Bajares, M; Comparato, MR; Yabur, JA | 1 |
| Bahamondes, L; Baracat, EC; da Cunha, DC; de Andrade, RP; de Melo, NR; Guazelli, CA; Halbe, HW; Lemgruber, M; Petracco, A | 1 |
| Huber, J; Wenzl, R | 1 |
| Kaper, RF; Qian, SZ; Sang, GW; Zheng, HM; Zheng, SR | 1 |
| Beerthuizen, R; Bennink, HC; Hout, J; Mäkäräinen, L; Massai, R; van Beek, A | 1 |
| Bouw, GM; Foidart, JM; Gerlinger, C; Heithecker, R; Wuttke, W | 1 |
| Bunyavejchevin, S; Machielsen, C; Punnahitananda, S; Reinprayoon, D; Taneepanichskul, S; Thaithumyanon, P; Tosukhowong, P; van Beek, A | 1 |
| Cronin, M; Düsterberg, B; Endrikat, J; Gerlinger, C; Ruebig, A; Schmidt, W | 1 |
| Bilotta, P; Favilli, S | 3 |
| al-Yacoub, G; Back, DJ; Jütting, G; Kuhnz, W; Ormesher, SE; Power, J | 1 |
| Huber, PR; Mall-Haefeli, M; Werner-Zodrow, I | 1 |
| Coelingh Bennink, HJ; Dieben, TO; van Beek, A | 1 |
| Bertolotto, A; Fioretti, P; Fruzzetti, F; Giampietro, O; Melis, G; Miccoli, R; Navalesi, R; Orlandi, MC; Ricci, C | 1 |
| Alvarado, M; Brito, V; Yabur, JA | 1 |
| Benagiano, G | 1 |
| Christie, T | 1 |
| Chailurkit, L; Chaturachinda, K; Piromsawasdi, S; Rojanasakul, A; Sirimongkolkasem, R; Sumavong, V | 1 |
| Rekers, H | 1 |
| Cullberg, G; Hamberger, L; Mattsson, LA; Mobacken, H; Samsioe, G | 1 |
1 review(s) available for desogestrel and Body Weight
| Article | Year |
|---|---|
Pharmacokinetics of Implanon. An integrated analysis.
Topics: Absorption; Area Under Curve; Biological Availability; Body Weight; Contraceptive Agents, Female; Cross-Sectional Studies; Desogestrel; Drug Implants; Female; Humans; Infusions, Intravenous; Longitudinal Studies; Progesterone Congeners; Radioimmunoassay; Vinyl Compounds | 1998 |
34 trial(s) available for desogestrel and Body Weight
| Article | Year |
|---|---|
[Efficacy and safety of drospirenone-ethinylestradiol on contraception in healthy Chinese women: a multicenter randomized controlled trial].
Topics: Adult; Androstenes; Body Weight; China; Contraception; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Female; Follow-Up Studies; Humans; Menstrual Cycle; Patient Satisfaction; Premenstrual Syndrome; Surveys and Questionnaires; Young Adult | 2009 |
Safety of the etonogestrel-releasing implant during the immediate postpartum period: a pilot study.
Topics: Adolescent; Adult; Analysis of Variance; Blood Cell Count; Body Mass Index; Body Weight; C-Reactive Protein; Chi-Square Distribution; Cholesterol; Contraceptive Agents, Female; Cytokines; Desogestrel; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Infant, Newborn; Lactation; Medroxyprogesterone Acetate; Patient Selection; Pilot Projects; Statistics, Nonparametric; Waist Circumference | 2009 |
Efficacy and safety of the combined oral contraceptive ethinylestradiol/drospirenone (Yasmin) in healthy Chinese women: a randomized, open-label, controlled, multicentre trial.
Topics: Adult; Androstenes; Body Water; Body Weight; China; Contraception; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Female; Follow-Up Studies; Humans; Menstrual Cycle | 2010 |
A randomized study over 13 cycles to assess the influence of oral contraceptives containing ethinylestradiol combined with drospirenone or desogestrel on carbohydrate metabolism.
Topics: Adolescent; Adult; Androstenes; Blood Glucose; Blood Pressure; Body Weight; C-Peptide; Carbohydrate Metabolism; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Fasting; Fatty Acids, Nonesterified; Female; Glucose Tolerance Test; Humans; Insulin; Kinetics | 2003 |
Glucose metabolism and insulin resistance in women with polycystic ovary syndrome during therapy with oral contraceptives containing cyproterone acetate or desogestrel.
Topics: Adult; Anthropometry; Blood Glucose; Body Weight; C-Peptide; Contraceptives, Oral, Hormonal; Cyproterone Acetate; Desogestrel; Ethinyl Estradiol; Female; Glucose; Glucose Tolerance Test; Hormones; Humans; Insulin; Insulin Resistance; Polycystic Ovary Syndrome | 2003 |
A multicenter phase IIb study of a novel combination of intramuscular androgen (testosterone decanoate) and oral progestogen (etonogestrel) for male hormonal contraception.
Topics: Administration, Oral; Adolescent; Adult; Body Weight; Contraception; Desogestrel; Follicle Stimulating Hormone; Humans; Injections, Intramuscular; Lipids; Luteinizing Hormone; Male; Middle Aged; Sperm Count; Testosterone | 2005 |
Effects on cycle control and bodyweight of the combined contraceptive ring, NuvaRing, versus an oral contraceptive containing 30 microg ethinyl estradiol and 3 mg drospirenone.
Topics: Administration, Oral; Adult; Androstenes; Body Composition; Body Weight; Contraceptive Devices, Female; Contraceptives, Oral; Desogestrel; Drug Combinations; Ethinyl Estradiol; Humans; Intrauterine Devices; Menstrual Cycle; Patient Compliance | 2006 |
[Clinical study of two monophase oral contraceptives with desogestrel].
Topics: Blood Pressure; Body Mass Index; Body Weight; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Desogestrel; Dose-Response Relationship, Drug; Ethinyl Estradiol; Female; Humans; Menstrual Cycle; Prospective Studies | 2007 |
Clinical experience with NuvaRing in daily practice in Switzerland: cycle control and acceptability among women of all reproductive ages.
Topics: Adolescent; Adult; Age Factors; Blood Pressure; Body Weight; Contraceptive Devices, Female; Desogestrel; Drug Combinations; Drug Delivery Systems; Ethinyl Estradiol; Female; Humans; Menstrual Cycle; Middle Aged; Patient Acceptance of Health Care; Pregnancy; Prospective Studies; Surveys and Questionnaires; Switzerland | 2007 |
Effects of low-dose oral contraceptives on body weight: results of a randomized study of up to 13 cycles of use.
Topics: Adolescent; Adult; Body Weight; Contraception; Contraceptives, Oral; Desogestrel; Drug Combinations; Ethinyl Estradiol; Female; Humans; Menstrual Cycle; Middle Aged; Norethindrone; Norgestrel; Patient Satisfaction; Time Factors; Weight Gain | 2007 |
[Effect of hormonal contraceptives containing 0.05 mg ethinyl estradiol and 0.125 mg desogestrel in normophasic regimen (Oviol)].
Topics: Adolescent; Adult; Body Weight; Clinical Trials as Topic; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Desogestrel; Drug Combinations; Ethinyl Estradiol; Female; Humans; Menstruation; Norpregnenes | 1982 |
Comparative effects of the oral contraceptive combinations 0.150 mg desogestrel + 0.030 mg ethinyloestradiol and 0.150 mg levonorgestrel + 0.030 mg ethinyloestradiol on lipid and lipoprotein metabolism in healthy female volunteers.
Topics: Adolescent; Adult; Body Weight; Cholesterol Esters; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Fatty Acids; Female; Humans; Levonorgestrel; Lipids; Lipoproteins; Lipoproteins, HDL; Lipoproteins, LDL; Lipoproteins, VLDL; Norgestrel; Norpregnenes; Phosphatidylcholines; Triglycerides | 1982 |
Clinical trial of an oral contraceptive containing desogestrel and ethinyl estradiol.
Topics: Adult; Blood Pressure; Body Weight; Clinical Trials as Topic; Contraceptives, Oral; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Female; Humans; Menstruation; Norpregnenes; Pregnancy | 1982 |
Multicenter study in Hungary with a 30 micrograms ethinylestradiol- and 150 micrograms desogestrel-containing monophasic oral contraceptive.
Topics: Adolescent; Adult; Blood Pressure; Body Weight; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Female; Humans; Hungary; Menstrual Cycle | 1994 |
Comparative profiles of reliability, cycle control and side effects of two oral contraceptive formulations containing 150 micrograms desogestrel and either 30 micrograms or 20 micrograms ethinyl oestradiol.
Topics: Adolescent; Adult; Body Weight; Chemistry, Pharmaceutical; Contraceptives, Oral, Combined; Desogestrel; Double-Blind Method; Ethinyl Estradiol; Female; Humans; Menstrual Cycle; Pancuronium; Risk Factors | 1993 |
Long-interval treatment regimen with a desogestrel-containing oral contraceptive.
Topics: Adolescent; Adult; Body Weight; Contraceptives, Oral, Hormonal; Desogestrel; Ethinyl Estradiol; Female; Humans; Surveys and Questionnaires; Uterine Hemorrhage | 1993 |
A multicenter clinical trial in Nigeria with a low-dose oral contraceptive, Marvelon.
Topics: Adolescent; Adult; Blood Pressure; Body Weight; Contraceptives, Oral; Desogestrel; Dose-Response Relationship, Drug; Female; Humans; Menstrual Cycle; Nigeria | 1993 |
Release characteristics, ovarian activity and menstrual bleeding pattern with a single contraceptive implant releasing 3-ketodesogestrel.
Topics: Adolescent; Adult; Blood Pressure; Body Weight; Cervix Mucus; Desogestrel; Drug Implants; Female; Gonadal Steroid Hormones; Humans; Menstruation; Ovarian Follicle; Ovary; Ovulation; Progesterone Congeners; Sex Hormone-Binding Globulin; Ultrasonography | 1993 |
Comparative evaluation of the androgenicity of four low-dose, fixed-combination oral contraceptives.
Topics: Adult; Androgens; Blood Pressure; Body Weight; Carrier Proteins; Contraceptives, Oral, Combined; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Desogestrel; Dihydrotestosterone; Dose-Response Relationship, Drug; Ethinyl Estradiol; Female; Humans; Hydroxyprogesterones; Norgestrel; Norpregnenes; Progesterone Congeners; Prospective Studies; Serum Albumin; Sex Hormone-Binding Globulin; Testosterone | 1995 |
A twelve-month comparative clinical investigation of two low-dose oral contraceptives containing 20 micrograms ethinylestradiol/75 micrograms gestodene and 20 micrograms ethinylestradiol/150 micrograms desogestrel, with respect to efficacy, cycle control
Topics: Adolescent; Adult; Amenorrhea; Austria; Body Weight; Contraceptives, Oral; Desogestrel; Dose-Response Relationship, Drug; Drug Combinations; Drug Tolerance; Dysmenorrhea; Ethinyl Estradiol; Female; France; Headache; Humans; Longitudinal Studies; Menstrual Cycle; Nausea; Norpregnenes; Progesterone Congeners; Time Factors | 1995 |
Contraceptive efficacy and acceptability of a monophasic oral contraceptive containing 30 microg ethinyl estradiol and 150 microg desogestrel in Latin-American women.
Topics: Acne Vulgaris; Adult; Argentina; Blood Pressure; Body Weight; Contraception; Contraceptives, Oral, Synthetic; Desogestrel; Drug Combinations; Estradiol Congeners; Ethinyl Estradiol; Female; Humans; Incidence; Treatment Outcome; Uterine Hemorrhage; Venezuela | 1998 |
Efficacy and acceptability of two monophasic oral contraceptives containing ethinylestradiol and either desogestrel or gestodene.
Topics: Acne Vulgaris; Adult; Blood Pressure; Body Weight; Brazil; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Desogestrel; Estradiol Congeners; Ethinyl Estradiol; Female; Humans; Menstrual Cycle; Norpregnenes; Progesterone Congeners; Severity of Illness Index; Uterine Hemorrhage | 1998 |
A randomized multicenter study comparing the efficacy and bleeding pattern of a single-rod (Implanon) and a six-capsule (Norplant) hormonal contraceptive implant.
Topics: Adult; Amenorrhea; Blood Pressure; Body Weight; China; Contraceptive Agents, Female; Desogestrel; Female; Hemoglobins; Humans; Levonorgestrel; Patient Acceptance of Health Care; Progesterone Congeners; Uterine Hemorrhage; Vinyl Compounds | 1999 |
A comparative investigation of contraceptive reliability, cycle control and tolerance of two monophasic oral contraceptives containing either drospirenone or desogestrel.
Topics: Adult; Androstenes; Body Weight; Contraceptives, Oral, Synthetic; Desogestrel; Europe; Female; Humans; Menstrual Cycle; Menstruation Disturbances; Pregnancy; Pregnancy Rate; Premenstrual Syndrome; Progesterone Congeners | 2000 |
Open, multicenter comparison of efficacy, cycle control, and tolerability of a 23-day oral contraceptive regimen with 20 microg ethinyl estradiol and 75 microg gestodene and a 21-day regimen with 20 microg ethinyl estradiol and 150 microg desogestrel.
Topics: Adolescent; Adult; Blood Pressure; Body Weight; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Female; Humans; Menstrual Cycle; Norpregnenes; Time Factors; Treatment Outcome; Uterine Hemorrhage | 2001 |
[A clinical trial of a monophasic contraceptive preparation containing ethinyl estradiol and desogestrel].
Topics: Adult; Body Weight; Contraceptives, Oral, Combined; Desogestrel; Drug Combinations; Ethinyl Estradiol; Female; Humans; Italy; Menstrual Cycle; Tablets | 1992 |
Pharmacokinetics and serum protein binding of 3-keto-desogestrel in women during three cycles of treatment with a low-dose combination oral contraceptive.
Topics: Adult; Blood Proteins; Body Weight; Cross Reactions; Desogestrel; Female; Humans; Protein Binding | 1992 |
Multicentre study with a new biphasic oral contraceptive containing ethinylestradiol and desogestrel. Report on efficacy, cycle control and adverse experiences with special emphasis on blood pressure and weight.
Topics: Blood Pressure; Body Weight; Contraceptives, Oral, Combined; Desogestrel; Drug Combinations; Ethinyl Estradiol; Female; Humans; Hypertension; Menstrual Cycle; Norpregnenes; Pregnancy | 1991 |
Metabolic effects of three new low-dose pills: a six-month experience.
Topics: Adult; Androgen Antagonists; Blood Glucose; Body Weight; Cholesterol; Contraceptives, Oral, Combined; Cyproterone; Cyproterone Acetate; Desogestrel; Ethinyl Estradiol; Female; Glucose Tolerance Test; Humans; Insulin; Norpregnenes; Progesterone Congeners; Random Allocation; Reference Values; Triglycerides | 1989 |
Comparison of two monophasic oral contraceptives: gestodene/ethinyl estradiol versus desogestrel/ethinyl estradiol.
Topics: Adult; Blood Pressure; Body Weight; Breast; Clinical Trials as Topic; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Female; Follow-Up Studies; Headache; Humans; Menstrual Cycle; Multicenter Studies as Topic; Nausea; Norpregnenes; Random Allocation | 1989 |
A clinical overview of a new triphasic contraceptive containing gestodene.
Topics: Adult; Blood Pressure; Body Weight; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Europe; Female; Humans; Menstrual Cycle; Multicenter Studies as Topic; New Zealand; Norethindrone; Norpregnenes; Patient Compliance; South America | 1989 |
Multicenter trial of a monophasic oral contraceptive containing ethinyl estradiol and desogestrel.
Topics: Adult; Blood Pressure; Body Weight; Clinical Trials as Topic; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Female; Humans; Menstrual Cycle; Menstruation Disturbances; Norpregnenes | 1988 |
Effects of a low-dose desogestrel-ethinylestradiol combination on hirsutism, androgens and sex hormone binding globulin in women with a polycystic ovary syndrome.
Topics: Adult; Androstenedione; Body Weight; Clinical Trials as Topic; Contraceptives, Oral; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Female; Hirsutism; Humans; Luteinizing Hormone; Middle Aged; Norpregnenes; Polycystic Ovary Syndrome; Sex Hormone-Binding Globulin; Testosterone | 1985 |
[Clinical evaluation of desogestrel, the first new-generation progestagen, practil 21, on 13,290 women and 74,967 cycles].
Topics: Adult; Blood Pressure; Body Weight; Clinical Trials as Topic; Contraceptives, Oral, Combined; Desogestrel; Drug Combinations; Drug Evaluation; Ethinyl Estradiol; Female; Follow-Up Studies; Humans; Italy; Menstrual Cycle; Norpregnenes; Progesterone Congeners | 1987 |
17 other study(ies) available for desogestrel and Body Weight
| Article | Year |
|---|---|
Effects of ethinyl estradiol plus desogestrel on premenstrual symptoms in Iranian women.
Topics: Adult; Body Weight; Contraceptives, Oral, Synthetic; Desogestrel; Female; Humans; Iran; Lipoproteins, HDL; Lipoproteins, LDL; Pregnancy; Premenstrual Syndrome; Treatment Outcome | 2014 |
Choice of the levonorgestrel intrauterine device, etonogestrel implant or depot medroxyprogesterone acetate for contraception after aspiration abortion.
Topics: Abortion, Induced; Adolescent; Adult; Body Weight; Choice Behavior; Contraception; Contraceptive Agents, Female; Decision Making; Desogestrel; Drug Implants; Educational Status; Female; Humans; Intimate Partner Violence; Intrauterine Devices, Medicated; Levonorgestrel; Logistic Models; Medroxyprogesterone Acetate; Middle Aged; Multivariate Analysis; Pregnancy; Pregnancy, Unplanned; Prospective Studies; Racial Groups; Stress, Psychological; Young Adult | 2015 |
Metabolic safety of the etonogestrel contraceptive implant in healthy women over a 3-year period.
Topics: Adult; Body Mass Index; Body Weight; Contraceptive Agents, Female; Desogestrel; Female; Humans; Insulin; Insulin Resistance; Prospective Studies; Women's Health; Young Adult | 2016 |
Changes in body composition in women using long-acting reversible contraception.
Topics: Adult; Analysis of Variance; Body Composition; Body Mass Index; Body Weight; Contraception; Contraceptive Agents, Female; Delayed-Action Preparations; Desogestrel; Drug Implants; Female; Humans; Intrauterine Devices, Copper; Levonorgestrel; Linear Models; Prospective Studies; Young Adult | 2017 |
Pregnancy at time of change of Implanon implant.
Topics: Body Weight; Contraceptive Agents, Female; Desogestrel; Drug Implants; Drug Interactions; Female; Humans; Pregnancy; Pregnancy, Unplanned; Product Surveillance, Postmarketing | 2009 |
Etonogestrel implant in adolescents: evaluation of clinical aspects.
Topics: Adolescent; Blood Pressure; Body Weight; Chi-Square Distribution; Contraception; Contraceptive Agents, Female; Desogestrel; Drug Implants; Female; Humans; Prospective Studies; Surveys and Questionnaires | 2011 |
Spontaneous snapping of an Implanon in two halves in situ.
Topics: Adult; Body Weight; Contraceptive Agents, Female; Desogestrel; Female; Humans; Progesterone Congeners; Time Factors; Vinyl Compounds | 2003 |
Combined administration of low-dose gossypol acetic acid with desogestrel/mini-dose ethinylestradiol/testosterone undecanoate as an oral contraceptive for men.
Topics: Animals; Body Weight; Contraceptive Agents, Male; Contraceptives, Oral, Synthetic; Desogestrel; Ethinyl Estradiol; Fertility; Gossypol; Male; Organ Size; Random Allocation; Rats; Rats, Wistar; Sexual Behavior, Animal; Sperm Motility; Spermatogenesis; Testis; Testosterone | 2004 |
[Hormonal contraception with marvelon. Experiences with marvelon in gynecologic practice--a multicenter study by 265 gynecologists on over 26,000 women].
Topics: Acne Vulgaris; Adolescent; Adult; Body Weight; Contraceptives, Oral; Contraceptives, Oral, Hormonal; Desogestrel; Female; Humans; Menstruation; Norpregnenes | 1983 |
[Comparison of a 2-phase preparation (Oviol 22) with a low-dose 1-phase preparation (Ovoresta M)].
Topics: Adult; Body Weight; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Sequential; Desogestrel; Drug Combinations; Ethinyl Estradiol; Female; Humans; Lynestrenol; Menstrual Cycle; Norpregnenes | 1984 |
[The desogestrel-ethinyl estradiol combination and overweight: current data].
Topics: Adolescent; Adult; Body Weight; Contraceptives, Oral, Synthetic; Desogestrel; Estradiol Congeners; Ethinyl Estradiol; Female; Humans; Obesity; Progesterone Congeners; Time Factors | 1995 |
Bone mineral density during long-term use of the progestagen contraceptive implant Implanon compared to a non-hormonal method of contraception.
Topics: Absorptiometry, Photon; Adolescent; Adult; Body Weight; Bone Density; Contraceptive Agents, Female; Desogestrel; Drug Implants; Estradiol; Female; Femur; Humans; Intrauterine Devices; Progesterone Congeners; Prospective Studies; Radius; Vinyl Compounds | 2000 |
Effects of the etonogestrel-releasing contraceptive implant (Implanon on parameters of breastfeeding compared to those of an intrauterine device.
Topics: Adult; Area Under Curve; Body Height; Body Weight; Breast Feeding; Contraceptive Agents, Female; Desogestrel; Female; Humans; Infant; Intrauterine Devices, Medicated; Lactation; Male; Milk, Human; Prospective Studies; Time Factors; Vinyl Compounds | 2000 |
[Clinical experience with Mercilon and Marvelon with special reference to ovarian function].
Topics: Adolescent; Adult; Blood Pressure; Body Weight; Contraceptives, Oral, Combined; Desogestrel; Dose-Response Relationship, Drug; Ethinyl Estradiol; Female; Gonadal Steroid Hormones; Humans; Menstrual Cycle; Norpregnenes; Ovulation; Progesterone Congeners | 1991 |
Clinical evaluation of a new combined oral contraceptive desogestrel--ethinylestradiol.
Topics: Adolescent; Adult; Blood Pressure; Body Weight; Cervix Mucus; Cholesterol; Contraceptives, Oral, Combined; Desogestrel; Endometrium; Ethinyl Estradiol; Female; Humans; Libido; Lipoproteins; Menstrual Cycle; Menstruation; Norpregnenes; Triglycerides; Vagina | 1989 |
Effects of combined ethinylestradiol and desogestrel on hormone profiles and sex hormone binding globulin in women with polycystic ovarian disease.
Topics: Adult; Body Weight; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Female; Gonadal Steroid Hormones; Gonadotropins, Pituitary; Hormones; Humans; Longitudinal Studies; Menstruation Disturbances; Norpregnenes; Polycystic Ovary Syndrome; Sex Hormone-Binding Globulin | 1987 |
Clinical evaluation of a monophasic ethinylestradiol/desogestrel-containing oral contraceptive.
Topics: Adult; Blood Pressure; Body Weight; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Female; Humans; Menstrual Cycle; Norpregnenes; Progesterone Congeners | 1988 |